Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.95    -0.25 (-7.81%)
Bid:
2.95
Ask:
3.11
Spread: 0.16 (5.424%)
Market Cap: £5.38m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

AGM Statement

12 Jan 2018 07:00

RNS Number : 6646B
Nanoco Group PLC
12 January 2018
 

12 Jan 2018

NANOCO GROUP PLC

("Nanoco" or "the Company")

AGM Statement

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, will hold its Annual General Meeting ("AGM") later this morning at its headquarters in Manchester.

Dr Chris Richards, Nanoco's Chairman, will make the following statement:

"Since we updated the market in mid-November with our preliminary results we have continued to make good progress in the commercialisation of our CFQD® nanoparticle technology. This was underlined by a successful CES in Las Vegas this week, which was attended by industry players, customers and the financial community and generated several leads for both TVs and monitor products.

"We demonstrated a number of TVs and monitors equipped with Nanoco product at CES and we also launched the next generation of NANOCO CFQD® FINE COLOR FILM™. This new film delivers outstanding levels of brightness and colour performance, as the industry progresses on the roadmap to DCI-P3 and BT.2020 standards and away from cadmium-based solutions."

"We are encouraged by the increasing number of Nanoco equipped display products moving through to commercial production with customers in Asia. 

 "With the benefit of a strengthened balance sheet, the progress being made with our go-to-market strategy in Display and the emerging opportunities in other markets, we look forward to the year ahead with confidence."

 

For further information, please contact:

 

MHP Communications

Tel: +44 (0) 20 3128 8788

Reg Hoare / Andrew Leach / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nanotechnology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare and solar.

 

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEAKFFFDXPEFF
Date   Source Headline
18th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jul 20247:00 amRNSHolding(s) in Company
11th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:01 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:00 amRNSYear End Trading Update
1st Jul 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSBlocklisting Six Monthly Return
31st May 20245:19 pmRNSTotal Voting Rights and Share Capital
9th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.